The STEP clinical trial program demonstrated that semaglutide 2.4 mg produced average weight loss of approximately 15% of body weightresults comparable to bariatric surgery
2 In addition to metabolic and androgen improvements, GLP-1 RAs appear to influence menstrual cyclicity positively
You can report any suspected side effects to the MHRA Yellow Card scheme, which helps monitor medicine safety
Also, MG or glyoxal reduced mitochondrial membrane potential, suppressed the activities of respiratory chain complexes, decreased ATP production, and elevated reactive oxygen species (ROS) levels 24,25,26
(More information) -Tocopherol functions as a chain-breaking antioxidant, preventing the propagation of free radicals in membranes and plasma lipoproteins